Feb 29 |
Q4 2023 Rxsight Inc Earnings Call
|
Feb 29 |
RxSight, Inc. (RXST) Q4 2023 Earnings Call Transcript
|
Feb 28 |
RxSight Non-GAAP EPS of -$0.13 beats by $0.14, revenue of $28.6M beats by $0.74M
|
Feb 28 |
RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023
|
Feb 28 |
RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 28 |
Earnings Scheduled For February 28, 2024
|
Feb 27 |
RxSight Q4 2023 Earnings Preview
|
Feb 14 |
RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
|
Jan 25 |
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
|
Jan 21 |
With 64% institutional ownership, RxSight, Inc. (NASDAQ:RXST) is a favorite amongst the big guns
|